Biosis Healing Participated the 15th Dental Implantology Conference with Vidasis® Oral Matrix

by Biosis Healing

From July 4th to 6th, 2024, 15th Dental Implantology Conference heald by Chinese Stomatological Association Dental Implant Professional Committee, was grandly opened at the Suzhou International Conference Hotel, Jiangsu.

Conference

The conference lasted for 3 days, with a tight schedule and rich and diverse contents, including lectures by well-known experts at home and abroad, multi-topic seminars on dentistry, critical thinking meetings of young experts, excellent cases and scientific research papers, teaching skills and popular science creation exchanges. The professional, authoritative, cutting-edge, vivid and informative content arrangement gave the participants in the dental field to get a wonderful experience in a short period of time!

Vidasis® Oral Matrix

Biosis Healing participated the 15th Dental Implantology Conference with Vidasis® Oral Matrix, showing Vidasis^® Oral Matrix and its clinical application in the field of oral prosthodontics to the participating experts and colleagues. Our exhibition stand attracted dental experts, scholars and industry elites from all over the country to visit.

Biosis Healing staff gave a professional explanation, so that everyone had a deeper understanding of the clinical application effect of Vidasis^® Oral Matrix, the advantages of SIS materials, the product barrier time, the surgical operation skills and other related issues.

Progress

Vidasis® Oral Matrix is prepared by Biosis Healing non-cross-linked extracellular matrix-derived biomaterials (SIS materials) with completely independent intellectual property rights, which is a strong guarantee for soft tissue repair and efficient osteogenesis. It has been more than two years since the certification of Vidasis^® Oral Matrix was obtained in 2022.

In the past two years, Biosis Healing has made steady progress, refined product quality internally, empowered team growth, promoted the layout of marketing network externally, carried out intensive clinical training for doctors, and occupied a place in the oral matrix market dominated by foreign brands. In February 2024, Biosis Healing oral matrix were approved by FDA (510k), becoming the first SIS material oral matrix product approved by FDA 510(k) in China, successfully entering the international market, and has been chosen and trusted by more and more dental experts.

In the future, Biosis Healing will continue to devote itself to the research and development and innovation of new products and technologies in the field of dentistry, and will continue to focus on the needs of patients and the development trend of the industry, and bring more innovation and possibilities to the development of the dental industry together with the best dental practitioners at home and abroad.